NCT07485036 Maternal Outcomes: Mood, Alcohol Use, and Depressive Symptoms
| NCT ID | NCT07485036 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Illinois Chicago |
| Condition | Postpartum Depression (PPD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-10-01 |
| Primary Completion | 2027-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-10-01 with a primary completion date of 2027-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to learn about depression and alcohol use in postpartum mothers and whether an intervention based on contingency management and problem-solving therapy (CM-PST) can help reduce these symptoms. The main questions it seeks to answer are: 1. How do new mothers fare with depressive symptoms and alcohol use in the first 12 months after giving birth? 2. Will a CM-PST intervention reduce depressive symptoms and alcohol use frequency among new mothers? 3. Is a CM-PST intervention practical for new mothers? The researchers will recruit approximately 30 new mothers and randomly select half to attend a 6-week CM-PST intervention. They will compare those who received the intervention versus those who did not to see if there are any differences in their depressive symptoms and alcohol usage. Participants will: * Complete 4 remote intervention sessions over 6 weeks * Conduct at-home urine drug tests 2x per week during the 6-week intervention * Answer online surveys about their mental health and alcohol use
Eligibility Criteria
Inclusion Criteria: * Biologically female * Age ≥18 years * Within 12 months postpartum * Able to provide informed consent Exclusion Criteria: * Serious medical or psychiatric conditions requiring hospitalization * Lifetime DSM-5 diagnosis of schizophrenia, bipolar disorder, or any psychiatric disorder * Current use of psychoactive drugs, medication to treat problematic alcohol use, or depression * Participation in past 6 months in problematic alcohol use or substance use treatment * Unable to provide consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07485036 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Postpartum Depression (PPD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07485036 currently recruiting?
Yes, NCT07485036 is actively recruiting participants. Contact the research team at hhalli2@uic.edu for enrollment information.
Where is the NCT07485036 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT07485036 clinical trial?
NCT07485036 is sponsored by University of Illinois Chicago. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.